Xtant Medical Partners with Dilon Technologies for Exclusive Distribution of HEMOBLAST® Bellows in the U.S. Xtant Medical and Dilon Technologies announced an exclusive U.S. distribution agreement for the innovative HEMOBLAST® Bellows, enhancing surgical hemostatic solutions.

Xtant Medical Partners with Dilon Technologies for Exclusive Distribution of HEMOBLAST® Bellows in the U.S. #USA #Newport_News #Xtant_Medical #Dilon_Technologies #HEMOBLAST

Dilon Technologies Introduces MarginProbe® 2 for Enhanced Breast Cancer Surgery Success Dilon Technologies has announced the FDA approval and U.S. launch of MarginProbe® 2, a breakthrough in intraoperative margin assessment for breast cancer surgeries, aiming to improve patient outcomes.

Dilon Technologies Introduces MarginProbe® 2 for Enhanced Breast Cancer Surgery Success #USA #Breast_Cancer #Newport_News #Dilon_Technologies #MarginProbe®

Dilon Technologies Secures $9 Million Investment for Growth in Medical Devices Dilon Technologies has announced a $9 million investment aimed at bolstering its impact in the medical device industry, particularly in cancer treatment and surgery.

Dilon Technologies Secures $9 Million Investment for Growth in Medical Devices #United_States #Newport_News #Dilon_Technologies #HEMOBLAST #MarginProbe